Acta Scientific Gastrointestinal Disorders

Research Article Volume 8 Issue 4

The Main Criteria for Choosing the Composition and Technology of a New Combined Anti-Inflammatory Drug in the Form of Tablets

Zufarova ZH* and Yunusova HM

Tashkent Pharmaceutical Institute, Department of Industrial Technology of Medicines Tashkent, Uzbekistan

*Corresponding Author: Zufarova ZH, Tashkent Pharmaceutical Institute, Department of Industrial Technology of Medicines Tashkent, Uzbekistan

Received: March 03, 2025; Published: March 27, 2025

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) are one of the most widely used groups of drugs in clinical practice, which are used for the symptomatic treatment of inflammatory processes accompanying many diseases. The most common among them is acetylsalicylic acid (ASA), which is part of the group of acidic NSAIDs.

Keywords: Composition; Combined; Anti-Inflammatory; Drug; Tablets

References

  1. Astakhova AV. “Nonsteroidal anti-inflammatory drugs (NSAIDs): spectrum of adverse reactions / A.V. Astakhova”. Drug Safety 4 (2007): 27-30.
  2. Alyavi BA. “Topical issues of the safety of the use of non-steroidal anti-inflammatory drugs in clinical practice: scientific publication”. Neurology (2012): 63-66.
  3. Mavlyanov IR. “Non-steroidal anti-inflammatory drugs: mechanism of action, search for new effective and safe drugs”. Medical Science of Uzbekistan 1 (2002): 94-97.
  4. Kaminny AI. “Therapy with antiplatelet and nonsteroidal anti-inflammatory drugs. The ratio of risk and benefit”. The Attending Physician 7 (2009): 49-54.
  5. Walter MB., et al. “Step-by-step control in the production of tablets”. Medicine (1982): 208.
  6. State Pharmacopoeia XI, issue 2”. Medicine (1990): 398.

Citation

Citation: Zufarova ZH and Yunusova HM. “The Main Criteria for Choosing the Composition and Technology of a New Combined Anti-Inflammatory Drug in the Form of Tablets".Acta Scientific Gastrointestinal Disorders 8.4 (2025): 36-40.

Copyright

Copyright: © 2025 Zufarova ZH and Yunusova HM. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.

Contact US